临床试验

Suprachoroidal Administration in Subjects With Metastases to the Choroid

NCT：NCT06643884 · RECRUITING

NCT编号NCT06643884

状态RECRUITING

开始日期2024-12-16

完成时间2027-10-31

SponsorAura Biosciences (INDUSTRY)

First posted2024-10-16

Last updated2026-10-08

简要摘要

The primary objective is to assess the safety and tolerability of bel-sar treatment in subjects with metastases to the choroid from any primary solid tumor.

官方来源

在 ClinicalTrials.gov 上查看 →

数据来自 ClinicalTrials.gov API。有关最新状态，请参阅官方记录。